MDedge Cardiocast

By MDedge

What's MDedge Cardiocast about?

MDedge Cardiocast is the weekly podcast from Cardiology News. The information in this podcast is provided for informational and educational purposes only.

Download our free app to listen on your phone

MDedge Cardiocast episodes:

12.27.2019
Top stories from the American Heart Association scientific sessions
ISCHEMIA trial hailed as practice changing The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves. DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics Further analyses from the DAPA-HF trial showed dapagliflozin cut...
12.20.2019
Vascepa gains event-reduction nod; diabetes ups ischemic risks
Vascepa approved for cardiovascular risk reduction The FDA’s decision on cutting events in high-risk patients was based primarily on the REDUCE-IT trial. ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding Novel oral anticoagulants may...
12.13.2019
Post-STEMI events less likely in women; bariatric surgery may lower stroke risk
Women have fewer cardiovascular events after non–ST-segment elevation ACS But they also remain undertreated with guideline-directed therapies. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * ...
12.06.2019
New trick for old drug; Vascepa cost effective for CV reduction
Icosapent ethyl cost effective in REDUCE-IT analysis Treatment with the fish-derived drug Vascepa for CV event reduction is more effective and less costly than placebo. * * * Help us make this podcast better! Please take our short...
11.29.2019
Card Talk: TAVR and glass ceilings
This week’s Cardiocast is devoted entirely to Card Talk with cardiologist brothers Jim and Jerry Dwyer. They welcome two structural interventionalists at the Structural Heart and Valve Center at Emory Healthcare, Kendra J. Grubb, MD, and Isida Byku,...
11.26.2019
ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special
In this special meeting edition of the Cardiocast, MDedge Cardiology editor Catherine Hackett is joined by MDedge reporters Mitchel L. Zoler, Bruce Jancin, and Richard Mark Kirkner. The MDedge cardiology team reviews three big stories from the 2019 annual scientific...
11.22.2019
Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF
ISCHEMIA trial hailed as practice changing The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019...
11.15.2019
Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk
Getting high heightens stroke, arrhythmia risks Cannabis use or abuse among the young was associated with adverse cardiovascular consequences in two studies. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * ...
11.08.2019
How risk factors in childhood translate to CV outcomes in adulthood
Closing the missing link between childhood risk factors and adult cardiovascular outcomes Prescient childhood cohort studies launched in the 1970s are paying off. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * *...
11.01.2019
Driving while defibrillating; hypertension holds greater risk in black patients
Patients frequently drive too soon after ICD implantation Many patients didn’t recall ever receiving instruction about when to drive again. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * *...
10.25.2019
AFib hits Native Americans hard; TAVR shown durable, safe after 5 years
Strong showing for TAVR after 5 years in PARTNER 2ATranscatheter and surgical aortic valve replacement had similar rates of death or disabling stroke. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * ...
10.22.2019
Practice changing prevention data from ESC 2019 Part II
MDedge reporters discuss the latest in practice-changing data from the 2019 annual congress of the European Society of Cardiology in Paris. Join Mitchel L. Zoler, Bruce Jancin, Kari Oakes, and MDedge Cardiology editor Catherine Hackett as they discuss what they reported from the annual meeting.
10.18.2019
Statins tied to skin, soft tissue infections; new Card Talk episode
Statin use linked to risk of skin and soft tissue infections Use of statins was associated with increased risk of SSTIs at an average of 91, 182, and 365 days. Rivaroxaban trends toward higher thrombotic risk than vitamin...
10.11.2019
Troponin protocol rapidly rules out MI; hidden risk of moderate aortic stenosis
Novel cardiac troponin protocol rapidly rules out MI Three-quarters of patients who presented with suspected acute coronary syndrome were safely discharged from ED without hospital admission. Study questions preemptive TEVAR for extended type A dissections Interim results from...
10.04.2019
Sun sets on longer DAPT after PCI; inactivity boosts post-MI risk
Smoking and inactivity are the most powerful lifestyle risk factors after an MI Insufficient activity beats out obesity or above-target LDL cholesterol. Ticagrelor monotherapy tops DAPT for high-risk PCI patients TWILIGHT findings support move to shorter dual-antiplatelet therapy....
09.27.2019
Cardiology dead last as women’s IM subspecialty choice
Cardiology dead last as women’s IM subspecialty choice Women in internal medicine residencies were more likely than men to report that they had never considered cardiology as a career choice. Beta-blockers effective, safe for HFrEF with renal dysfunction...
09.20.2019
An antiplatelet surprise; Europeans go low in cholesterol guidelines
Prasugrel bests ticagrelor in ACS in surprise findings ISAR-REACT 5 was the first-ever direct head-to-head look at two potent P2Y12 inhibitors in this setting. European cholesterol guidelines push LDL targets below 55 mg/dL PCSK-9 inhibitors are elevated to...
09.16.2019
SGLT-2 inhibitors and more practice changing data from ESC 2019
MDedge reporters discuss the latest in practice-changing data from the 2019 annual congress of the European Society of Cardiology in Paris. Join Mitchel L. Zoler, Bruce Jancin, Kari Oakes, and MDedge Cardiology editor Catherine Hackett as they discuss what they...
09.13.2019
Overweight BMI surpasses 'normal' and introducing the 'Card Talk' segment
We introduce a brand new format with Jerome Dwyer, MD, brother of our host, Jim Dwyer, MD, for a new segment that we're calling 'Card Talk' where Dr. Jim and Dr. Jerry talk about the current clinical state of cardiology...
09.06.2019
Dapagliflozin transforms into heart failure drug
DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug Proof that dapagliflozin significantly helped heart failure patients without diabetes recategorizes the drug as a major agent for treating heart failure. New hypertension cases...
08.30.2019
CV cost of smoking lasts a quarter century
This week in cardiology: PCSK9 inhibition cuts events in very-high-risk groups ODYSSEY OUTCOMES analyses peg prior CABG and polyvascular disease as targets for alirocumab. Cardiovascular cost of smoking may last up to 25 years Past smokers face...
08.23.2019
Two FDA approvals, smoking impacts CV health for 25 years
TAVR valves now FDA approved for low-risk patients The FDA's decision will expand TAVR access to younger, healthier patients. FDA approves baroreflex activation for advanced HF A phase 4 trial will investigate impact on hospitalizations and mortality....
08.16.2019
NSAIDS mediate CV risk and hypertension linked to dementia
The top news in cardiology: Midlife hypertension linked to dementia risk Elevated blood pressure in midlife is associated with risk of subsequent dementia, but whether the risk is treatable is unclear. Ambulatory BP...
08.09.2019
AI for AFib and acupuncture for angina
The top stories in cardiology: Artificial intelligence technology meets AFib detection An AI-enabled ECG model suggests clinical implications for early identification of atrial fibrillation. Older patients who stop statins may be increasing their cardiovascular risk Discontinuation of...
08.02.2019
Seven simple rules of heart failure risk - you only need two
The top news in cardiology: Meeting just 2 of 7 ‘simple’ goals lowers HF risk American Heart Association recommendations seem to lower risk even if only a couple of the 'Simple 7' are mastered. Increased...
07.26.2019
Air pollution correlated with cardio mortality; statins crush early seizure risk
Statins crush early seizure risk poststroke Statin initiation upon hospitalization for acute ischemic stroke was linked to a major antiseizure benefit in a Japanese study. Atherosclerotic disease risk persists after smoking cessation Clinicians should reinforce smoking cessation...
07.19.2019
Half of sudden cardiac deaths linked to silent MI; Uncontrolled hypertension and dementia
This week in cardiology: Systolic, diastolic BP each tied to adverse CV outcomes Diastolic hypertension can't be ignored, though systolic ultimately has a larger impact. Almost half of sudden cardiac deaths linked to prior silent MI Prior...
07.12.2019
Omega-3s cut heart failure; Fat-but-fit theory takes a hit
The top stories in cardiology: New findings cast more doubt on fat-but-fit theory Patients who are obese and metabolically healthy face higher cardiac risk Higher omega-3 fatty acid levels cut heart failure risk A large multi-ethnic cohort...
07.05.2019
Lipoprotein(a) levels and genes boost ischemic stroke risk
This week's top stories in cardiology: Lipoprotein(a) levels, genes boost ischemic stroke risk Could some elderly skip statins based on negative risk markers? Cardiac events jump after COPD exacerbation CAROLINA findings reaffirm linagliptin’s safety, free glimepiride...
06.28.2019
Continue using paclitaxel-eluting PAD devices
This week's top stories in cardiology: FDA Panel: Continue using paclitaxel-eluting PAD Devices, with caveats. Although the benefits of the devices were clear, the panel felt there should be a label change to warn of the late...
06.21.2019
CHD sped cognitive decline; choosing an antidiabetic for elderly patients
This week's top stories in cardiology: Cognitive decline sped up after CHD Genetic analysis links PCSK9 inhibition and CV mortality Which antidiabetic for elderly patients? It depends on their CV risk Pivotal trial shows HFrEF benefits from baroreceptor stimulation...
06.14.2019
Aspirin benefits, risks; Medicaid expansion and CV risks
This week's top stories in Cardiology. Updated systematic review of aspirin primary prevention shows benefits, risks GLP-1 RA dulaglutide yields cardiac gains, even in non–at-risk patients DOACs surpass warfarin in low-weight AFib patients Medicaid expansion...
06.07.2019
FFR changes coronary management; doctors want FDA out of the weeds
You can find more of our podcasts at http://www.mdedge.com/podcasts This week in cardiology: FFR changes coronary management in one-third of patients MADIT-CHIC: CRT aids patients with chemotherapy-induced cardiomyopathy Lipoprotein(a) levels can guide CV risk assessment and treatment Cannabis: Doctors...
05.31.2019
Novel cardiogenic shock nets survival, plus does ethnicity affect predisposition to components of metabolic syndrome?
You can find more of our podcasts on our website at http://www.mdedge.com/podcasts. This week in cardiology: Novel cardiogenic shock, PCI protocol nets 72% acute survival Energy drinks increase BP and disrupt the heart's electrical activity Syncope...
05.24.2019
Definition of carcinogenic shock
You can find more of our podcasts on our website: http://www.mdedge.com/podcasts This week in cardiology news: SCAI releases first definition of cardiogenic shock CABANA: Heart failure patients got biggest bang from AFib ablation Elderly concussion patients who used statins...
05.17.2019
Infection risk for cardiac rhythm device
Find more podcasts from MDedge on our website: https://www.mdedge.com/podcasts This week's top stories in cardiology: Risk score developed for cardiac-device infection AFib screening cuts hospitalizations and ED visits Arsenic exposure increases risk of left ventricular hypertrophy Ankylosing...
05.10.2019
Stroke risk, DOAC type in nonvalvular A-Fib patients
This week's top stories in clinical medicine: Single-center study outlines stoke risk, DOAC type in nonvalvular A-fib patients ACOG guidance addresses cardiac contributors to maternal mortality Higher serum leptin levels associated with PAD Employed physicians...
05.03.2019
Heightened stroke risk with long-term antibiotics?
This week's top stories in clinical cardiology: Long-term antibiotic use may heighten stroke, CHD risk Noninvasive FFRCT called ADVANCE in chest pain assessment Does BMI affect outcomes after ischemic stroke? Cardiac PET/CT can guise CAD therapy. You can...
04.28.2019
ACC 2019 Reporter's Breakdown
MDedge Cardiology editor Catherine Hackett hosts a conversation with Bruce Jancin and Mitch Zoler to talk about some of the research from the meeting as well as their general impressions. You can contact the show by emailing us at [email protected].
04.26.2019
Plant-based diet lowers risk of heart failure
This week in cardiology: Plant-based diet lowers risk of heart failure Medical societies endorse tiered certification for U.S. Heart-Valve care Ticagrelor doesn't beat clopidogrel in postfibrinolysis STEMI Cost gap widens between brand-name, generic drugs. ...
04.19.2019
PCI reduces mortality after STEMI in older adults
This week in clinical cardiology. PCI reduces mortality after STEMI in older adults. Canagliflozin lowers kidney failure risk in T2D: CREDENCE. Poor response to statins hikes risk of...
04.12.2019
Alirocumab reduces MIs
This week in clinical cardiology: Alirocumab reduces both type 1 and 2 MIs. Despite failed primary endpoint, MI alert device has predictive value. Look for alcohol septal ablation in the next HOCM guideline. FDA: Forty ARBs free of nitrosamines....
04.05.2019
Too much hype for radial access PCI?
This week's top stories in clinical cardiology: Has radial access PCI been overhyped? Hospital TAVR volume matters to patient survival. Studies link TMAO to microbiome, reveal new heart disease target. ...
03.29.2019
Ticagrelor reversal and certification changes
This week, a novel drug that reverses ticagrelor’s effect looks promising, a new certification process for cardiologists is unveiled, intensive blood pressure monitoring may not help prevent a second stroke, and the FDA cautions against using...
03.22.2019
Top News from ACC 19
Cardiovascular prevention guidelines downgrade aspirin, high coronary artery calcium scores carry greater risks, an Apple Watch algorithm predicts AFib, and TAVR overtakes surgery in "historic" trials.
03.15.2019
New LDL-lowering drug is under FDA review
This week in MDedge Cardiocast: A novel drug lowers LDL in on top of maximums statins, invasive cardiology is a top money maker for hospitals, a meta-analysis parses the heart and kidney benefits of new diabetes drugs,...
03.08.2019
Forget what you learned about infective endocarditis
This week in MDedge Cardiocast: Infective endocarditis isn’t what it used to be, there’s a new, lower goal for Americans’ dietary intake of sodium, a drug to treat myeloma also raises heart failure risk, and Big Pharma...
03.01.2019
A weight-loss drug is poised for expanded indication
The Food and Drug Administration could extend eligibility for Belviq to lower-risk patients, the agency says a popular gout drug raises cardiovascular risk, an AHA statement targets CV risk factors in children, and a class action...
02.22.2019
Who is least adherent to statins, and more
Silent strokes are common after noncardiac surgery, troubling news about nonadherence to statins, what cardiologists need to know about ARVC, and how gender inequality in medicine affects the health of all women.
02.15.2019
What comes first with SGLT2 inhibitors – diabetes or heart failure?
This week in MDedge Cardiocast: Most tPA-eligible stroke patients now get treated within an hour, LAA closure can be treated safely in patients with prior hemorrhagic stroke, SGLT2 inhibitors are quickly morphing from diabetes to heart failure...

What's MDedge Cardiocast about?

Download our free app to listen on your phone

MDedge Cardiocast episodes:

Top stories from the American Heart Association scientific sessions

Vascepa gains event-reduction nod; diabetes ups ischemic risks

Post-STEMI events less likely in women; bariatric surgery may lower stroke risk

New trick for old drug; Vascepa cost effective for CV reduction

Card Talk: TAVR and glass ceilings

ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special

Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF

Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk

How risk factors in childhood translate to CV outcomes in adulthood

Driving while defibrillating; hypertension holds greater risk in black patients

AFib hits Native Americans hard; TAVR shown durable, safe after 5 years

Practice changing prevention data from ESC 2019 Part II

Statins tied to skin, soft tissue infections; new Card Talk episode

Troponin protocol rapidly rules out MI; hidden risk of moderate aortic stenosis

Sun sets on longer DAPT after PCI; inactivity boosts post-MI risk

Cardiology dead last as women’s IM subspecialty choice

An antiplatelet surprise; Europeans go low in cholesterol guidelines

SGLT-2 inhibitors and more practice changing data from ESC 2019

Overweight BMI surpasses 'normal' and introducing the 'Card Talk' segment

Dapagliflozin transforms into heart failure drug

CV cost of smoking lasts a quarter century

Two FDA approvals, smoking impacts CV health for 25 years

NSAIDS mediate CV risk and hypertension linked to dementia

AI for AFib and acupuncture for angina

Seven simple rules of heart failure risk - you only need two

Air pollution correlated with cardio mortality; statins crush early seizure risk

Half of sudden cardiac deaths linked to silent MI; Uncontrolled hypertension and dementia

Omega-3s cut heart failure; Fat-but-fit theory takes a hit

Lipoprotein(a) levels and genes boost ischemic stroke risk

Continue using paclitaxel-eluting PAD devices

CHD sped cognitive decline; choosing an antidiabetic for elderly patients

Aspirin benefits, risks; Medicaid expansion and CV risks

FFR changes coronary management; doctors want FDA out of the weeds

Novel cardiogenic shock nets survival, plus does ethnicity affect predisposition to components of metabolic syndrome?

Definition of carcinogenic shock

Infection risk for cardiac rhythm device

Stroke risk, DOAC type in nonvalvular A-Fib patients

Heightened stroke risk with long-term antibiotics?

ACC 2019 Reporter's Breakdown

Plant-based diet lowers risk of heart failure

PCI reduces mortality after STEMI in older adults

Alirocumab reduces MIs

Too much hype for radial access PCI?

Ticagrelor reversal and certification changes

Top News from ACC 19

New LDL-lowering drug is under FDA review

Forget what you learned about infective endocarditis

A weight-loss drug is poised for expanded indication

Who is least adherent to statins, and more

What comes first with SGLT2 inhibitors – diabetes or heart failure?